Alzamend Neuro, Inc.ALZNNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank56
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Percentile
P56
Within normal range
vs 5Y Ago
-317.6x
Contraction
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$-4.45M+55.0%
2024$-9.89M+33.4%
2023$-14.85M-20.6%
2022$-12.32M-148.8%
2021$-4.95M-35457.1%
2020$14000.00+100.3%
2019$-5.01M-68333.2%
2018$7341.00+134.1%
2017$-21501.00-
2016$0.00-